Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Hospital del Mar
Eastern Hepatobiliary Surgery Hospital
Charite University, Berlin, Germany
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Post Graduate Institute of Medical Education and Research, Chandigarh
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Tianjin Medical University Cancer Institute and Hospital
Seoul National University Hospital
Fudan University
First Affiliated Hospital of Wenzhou Medical University
Asian Institute of Gastroenterology, India
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Sun Yat-sen University
RenJi Hospital
Asan Medical Center
University of Magdeburg
Yonsei University
Yonsei University
Tianjin Medical University Cancer Institute and Hospital
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
University of Pisa
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Tongji Hospital
Fudan University
Simcere Pharmaceutical Co., Ltd
Charite University, Berlin, Germany